28
Participants
Start Date
September 30, 1998
Primary Completion Date
October 31, 1999
Study Completion Date
May 31, 2001
eniluracil
Will be given to either subject pre-operative and metastatic disease
conventional colon surgery
Only if the subject is amenable to surgical resections
Collaborators (1)
National Cancer Institute (NCI)
NIH
Glaxo Wellcome
INDUSTRY
University of Alabama at Birmingham
OTHER